SARC-F: A simple questionnaire to rapidly diagnose sarcopenia

Journal of the American Medical Directors Association

Volumn 14, Issue 8, 2013, Pages 531-532

  Malmstrom, Theodore K ^a   Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY; DIABETES MELLITUS; DISABILITY; EDITORIAL; GRIP STRENGTH; HIP FRACTURE; HUMAN; MUSCLE MASS; MUSCLE STRENGTH; OSTEOPOROSIS; QUESTIONNAIRE; RISK ASSESSMENT; SARC-F QUESTIONNAIRE; SARCOPENIA; WALKING SPEED;

EID: 84881262932     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2013.05.018     Document Type: Editorial

References (48)

1. Morley J.E., Baumgartner R.N., Roubenoff R., et al. Sarcopenia. JLab Clin Med 2001, 137:231-243.
2. Bauer J.M., Kaiser M.J., Sieber C.C. Sarcopenia in nursing home residents. JAm Med Dir Assoc 2008, 9:545-551.
3. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010, 39:412-423.
4. Morley J.E., Abbatecola A.M., Argiles J.M. Society on sarcopenia, Cachexia and Wasting Disorders Trialist Workshop. Sarcopenia with limited mobility: An international consensus. JAm Med Dir Assoc 2011, 12:403-409.
5. Fielding R.A., Vellas B., Evans W.J., et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International Working Group on Sarcopenia. JAm Med Dir Assoc 2011, 12:249-256.
6. Malmstrom TK, Miller DK, Herning MM, Morley JE, Low appendicular skeletal muscle mass (ASM) with limited mobility and poor health outcomes in middle-aged African Americans [published online ahead of print March 27, 2013]. JCachexia Sarcopenia Muscle.
7. Patel H.P., Syddall H.E., Jameson K., et al. Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: Findings from the Hertfordshire Cohort Study (HCS). Age Ageing 2013, 42:378-384.
8. Roman D., Mahoney K., Mohamadi A. Sarcopenia: What's in a name?. JAm Med Dir Assoc 2013, 14:80-82.
9. Cesari M., Vellas B. Sarcopenia: A novel clinical condition or still a matter for research?. JAm Med Dir Assoc 2012, 13:766-767.
10. Landi F., Liperoti R., Fusco D., et al. Sarcopenia and mortality among older nursing home residents. JAm Med Dir Assoc 2012, 13:121-126.
11. Neyens J.C., van Haastregt J.C., Dijcks B.P., et al. Effectiveness and implementation aspects of interventions for preventing falls in elderly people in long-term care facilities: A systematic review of RCTs. JAm Med Dir Assoc 2011, 12:410-425.
12. Choi M., Hector M. Effectiveness of intervention programs in preventing falls: A systematic review of recent 10 years and meta-analysis. JAm Med Dir Assoc 2012, 13:188.e13-188.e21.
13. Morley J.E., Rolland Y., Tolson D., Vellas B. Increasing awareness of the factors producing falls: The mini falls assessment. JAm Med Dir Assoc 2012, 13:87-90.
14. Vu M.Q., Weintraub N., Rubenstein L.Z. Falls in the nursing home: Are they preventable?. JAm Med Dir Assoc 2006, 7:S53-S58. 52.
15. Rapp K., Becker C., Cameron I.D., et al. Epidemiology of falls in residential aged care: Analysis of more than 70,000 falls from residents of Bavarian nursing homes. JAm Med Dir Assoc 2012, 13:187.e1-187.e6.
16. Arango-Lopera V.E., Arroyo P., Gutiérrez-Robledo L.M., et al. Mortality as an adverse outcome of sarcopenia. JNutr Health Aging 2013, 17:259-262.
17. Rougé Bugat M.E., Cestac P., Oustric S., et al. Detecting frailty in primary care: A major challenge for primary care physicians. JAm Med Dir Assoc 2012, 13:669-672.
18. Abellan van Kan G., Rolland Y.M., Morley J.E., Vellas B. Frailty: Toward a clinical definition. JAm Med Dir Assoc 2008, 9:71-72.
19. Morley J.E., Vellas B., Abellan van Kan G., et al. Frailty consensus: A call to action. JAm Med Dir Assoc 2013, 14:392-397.
20. Peters L.L., Boter H., Buskens E., Slaets J.P. Measurement properties of the Groningen Frailty Indicator in home-dwelling and institutionalized elderly people. JAm Med Dir Assoc 2012, 13:546-551.
21. Gobbens R.J., van Assen M.A., Luijkx K.G., et al. Determinants of frailty. JAm Med Dir Assoc 2010, 11:356-364.
22. Sjoblom S., Suuronen J., Rikkonen T., et al. Relationship between postmenopausal osteoporosis and the components of clinical sarcopenia. Maturitas 2013, 75:175-180.
23. Cederholm T., Cruz-Jentoft A.J., Maggi S. Sarcopenia and fragility fractures. Eur J Phys Rehabil Med 2013, 49:111-117.
24. Miyakoshi N, Hongo M, Mizutani Y, Shimada Y. Prevalence of sarcopenia in Japanese women with osteopenia and osteoporosis [published online ahead of print March 21, 2013]. JBone Miner Metab.
25. Morley J.E. Falls and fractures. JAm Med Dir Assoc 2007, 8:276-278.
26. Kaji H. Linkage between muscle and bone: Common catabolic signals resulting in osteoporosis and sarcopenia. Curr Opin Clin Nutr Metab Care 2013, 16:272-277.
27. Morley J.E. Frailty, falls, and fractures. JAm Med Dir Assoc 2013, 14:149-151.
28. Morley J.E. Osteoporosis and fragility fractures. JAm Med Dir Assoc 2011, 12:389-392.
29. Martinez-Reig M., Ahmad L., Duque G. The orthogeriatrics model of care: Systematic review of predictors of institutionalization and mortality in post-hip fracture patients and evidence for interventions. JAm Med Dir Assoc 2012, 13:770-777.
30. Migdal A., Yarandi S.S., Smiley D., Umpierrez G.E. Update on diabetes in the elderly and in nursing home residents. JAm Med Dir Assoc 2011, 12:627-632.e2.
31. Morley J.E. Diabetes mellitus: "The times they are a-changing.". JAm Med Dir Assoc 2012, 13:574-575.
32. Leenders M., Verdijk L.B., van der Hoeven L., et al. Patients with type 2 diabetesshow a greater decline in muscle mass, muscle strength, and functional capacity with aging. JAm Med Dir Assoc 2013, 14:585-592.
33. Sinclair A., Morley J.E., Rodriguez-Mañas L., et al. Diabetes mellitus in older people: Position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. JAm Med Dir Assoc 2012, 13:497-502.
34. Kanis J.A., McCloskey E., Johansson H., et al. FRAX(®) with and without bone mineral density. Calcif Tissue Int 2012, 90:1-13.
35. Leslie W.D., Lix L.M., Langsetmo L., et al. Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int 2011, 22:817-827.
36. Malmstrom T.K., Morley J.E. Sarcopenia: The target population. JFrailty Aging 2013, 2:55-56.
37. Yamada M., Arai H., Sonoda T., Aoyama T. Community-based exercise program is cost-effective by preventing care and disability in Japanese frail older adults. JAm Med Dir Assoc 2012, 13:507-511.
38. Singh N.A., Quine S., Clemson L.M., et al. Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: A randomized controlled trial. JAm Med Dir Assoc 2012, 13:24-30.
39. Valenzuela T. Efficacy of progressive resistance training interventions in older adults in nursing homes: A systematic review. JAm Med Dir Assoc 2012, 13:418-428.
40. Demontiero O., Herrmann M., Duque G. Supplementation with vitamin D and calcium in long-term care residents. JAm Med Dir Assoc 2011, 12:190-194.
41. McKinney J.D., Bailey B.A., Garrett L.H., et al. Relationship between vitamin D status and ICU outcomes in veterans. JAm Med Dir Assoc 2011, 12:208-211.
42. Mithal A., Bonjour J.P., Boonen S., et al. Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int 2013, 24:1555-1566. IOF CSA Nutrition Working Group.
43. Morley J.E., Argiles J.M., Evans W.J., et al. Society for Sarcopenia, Cachexia, and Wasting Disease. Nutritional recommendations for the management of sarcopenia. JAm Med Dir Assoc 2010, 11:391-396.
44. Tieland M., van de Rest O., Dirks M.L., et al. Protein supplementation improves physical performance in frail elderly people: A randomized, double-blind, placebo-controlled trial. JAm Med Dir Assoc 2012, 13:720-726.
45. Tieland M., Kirks M.L., van der Zwaluw N., et al. Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: A randomized, double-blind, placebo-controlled trial. JAm Med Dir Assoc 2012, 13:713-719.
46. Morley J.E. Anabolic steroids and frailty. JAm Med Dir Assoc 2010, 11:533-536.
47. Wittert G.A., Chapman I.M., Haren M.T., et al. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. JGerontol A Biol Sci Med Sci 2003, 58:618-625.
48. Morley J.E. Androgens and aging. Maturitas 2001, 38:61-71.